Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Medtronic paid CEO $9M in fiscal 2010

July 19, 2010 7:45 am | by MATTHEW PERRONE - AP Business Writer - Associated Press | News | Comments

Medtronic Inc., the world's largest medical device maker, paid Chief Executive William Hawkins $9 million in total compensation for fiscal 2010, roughly even with his earnings in the prior year, according to an analysis by the Associated Press.Hawkins, 56, took the reins of Medtronic in 2008,...

BD Biosciences Introduces CD4 Testing Product That Does Not Require Refrigeration

July 19, 2010 7:34 am | by Becton, Dickinson and Company | News | Comments

(July 19, 2010) -- BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced the creation of new dried reagents developed through a collaboration with ReaMetrix, a private biotechnology company based in Bangalore, India.  The new reagent

TOPICS:

World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients

July 19, 2010 6:38 am | by Bio-Medicine.Org | News | Comments

ZURICH , July 19, 2010 /- Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.[1] Spanning 28 countries across 4...

TOPICS:
Advertisement

Visage Imaging Releases Amira 5.3

July 19, 2010 6:35 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Calif. , July 19 /- Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D...

TOPICS:

Adaptation in mole blood aids tunnelling

July 19, 2010 6:34 am | by EurekAlert | News | Comments

(BioMed Central) "Super hemoglobin" allows moles to thrive underground. Researchers writing in the open-access journal BMC Evolutionary Biology have made the first identification of an adaptation in the blood of Eastern moles which allows more efficient transport of carbon dioxide,...

TOPICS:

New biotech company grows from MCG diabetes and genomic research

July 19, 2010 6:34 am | by EurekAlert | News | Comments

(Medical College of Georgia) A new biotech company has grown out of laboratory and clinical studies at the Medical College of Georgia with the goal of improving the diagnosis and treatment of diabetes and cancer. Dr. Jin-Xiong She, director of the MCG Center for Biotechnology and...

TOPICS:

Slim- 30 Herb Supplement: Undeclared Drug Ingredient

July 19, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

Product found to contain undeclared N-Desmethyl Sibutramine and traces of Sibutramine.

TOPICS:

MDMA (Ecstasy)-assisted psychotherapy relieves treatment-resistant PTSD

July 19, 2010 4:31 am | by EurekAlert | News | Comments

(SAGE Publications UK) MDMA (also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed. Clinical trial results out today in the Journal of Psychopharmacology, published by SAGE,...

TOPICS:
Advertisement

Johnny Quickparts Gets a Quote - Episode 2

July 19, 2010 1:31 am | by JohnnyQuickparts | Videos | Comments

With American manufacturing prowess at stake and with time running out, Johnny quickly explores the different options available for obtaining a rapid prototype quote for his new engineered part that just might save the world. It's do or die in this exciting second episode of Johnny's...

Healthscope recommends Carlyle, TPG takeover bid

July 18, 2010 4:45 pm | by The Associated Press | News | Comments

Healthscope Ltd., Australia's second-largest private hospital operator, said Monday its board has unanimously recommended a 2 billion Australian dollar ($1.72 billion) takeover offer from U.S. private equity firms Carlyle Group and TPG Capital.Carlyle and TPG have offered AU$6.26 a share for...

Microbial world's use of metals mostly unmapped

July 18, 2010 12:34 pm | by Lawrence Berkeley National Laboratory | News | Comments

Microbes boast a broader and more diverse array of metal-driven chemical processes than scientists imagined. In fact, most have yet to be discovered, according to a first-of-its-kind technique that catalogs all of the metals in a microbe. The method could lead to innovative clean energy...

TOPICS:

Long-term care of HIV survivors needs additional research, attention

July 18, 2010 2:32 am | by Baylor College of Medicine | News | Comments

As more effective treatments extend the lives of people with HIV, physicians need to research how best to provide care for these 'HIV survivors' as they age and acquire other chronic ailments, said experts at Baylor College of Medicine in a commentary that appears today in The Journal of...

TOPICS:

HIV testing should be routine in cancer care

July 18, 2010 12:33 am | by Baylor College of Medicine | News | Comments

In 2006, the U.S. Centers for Disease Control and Prevention recommended routine HIV testing in all healthcare settings as long as patients are given the opportunity to 'opt-out' or refuse the test. That recommendation is not widely followed, but it should be – especially in...

TOPICS:

Groundbreaking New Lung Imaging System

July 17, 2010 10:31 am | by ISRAEL21cdotcom | Videos | Comments

The FDA recently approved a groundbreaking new non-invasive, radiation-free lung imaging system created by Deep Breeze, Ltd, an Israeli company in Or Akiva. It is viewed by some as the most important medical imaging technology since ultrasound. It is being marketed by GE Healthcare in...

TOPICS:

ArmaGen® Re-engineers Erythropoietin for Brain Penetration

July 16, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES , July 16 /- Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading